JUSTIN RAY: Open Payments
NPI 1093013641 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57,864 in 141 payments from 14 companies in 2025. Trend: 2023 $27,309 · 2024 $28,293 · 2025 $57,864
Speaker / faculty: $32,260Honoraria: $17,226Travel & lodging: $5,293Food & beverage: $3,078Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 31 | $25,716 |
| Axsome Therapeutics, Inc. | 48 | $22,518 |
| ABBVIE INC. | 22 | $8,565 |
| Alkermes, Inc. | 13 | $279 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $208 |
| Vanda Pharmaceuticals Inc. | 5 | $169 |
| Averitas Pharma Inc. | 1 | $150 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Lundbeck LLC | 3 | $54 |
Products named: SPRAVATO, Auvelity, VRAYLAR, ARISTADA, CAPLYTA, FANAPT, QUTENZA, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
